100% correct ddwn,
A lot more to come, MSB is in an unprecedented position given the Covid-19 Pandemic and MSB has already demonstrated it's patent protected (over 1000 patents) MSC's proven effective in improving lung function in similar conditions. Further, recent clinical trials showed Remestemcel-L to either completely cure or significantly improve functional outcomes for all patients
The USA will use Remestemcel-L to treat patients with acute respiratory distress syndrome which is the most common cause of death relating to COVID-19T.
The FDA is the first domino and most significant to trial what we know will be an effective treatment IMO. Given the FDA has given go ahead, IMO then UK, France, Germany, Spain, Italy, the entire bloody EU and Australia will be announced in quick succession.
This is a significant milestone for MSB on it way to being an Australian made global Biotech rivaling the CSL story, with many other value accretive milestones to come shortly with respect to Covid-19 let alone its deep pipeline of applications of it's MSC's.
GLTAH
100% correct ddwn,A lot more to come, MSB is in an unprecedented...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
0.040(3.88%) |
Mkt cap ! $1.221B | |||
| Open | High | Low | Value | Volume |
| $1.05 | $1.09 | $1.03 | $4.786M | 4.482M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 40 | 122573 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 12997 | 24 |
View Market Depth
| Last trade - 14.50pm 02/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |